Importantly, Kaplan–Meier analysis showed that PLEKHA1-TACC2 expression combined with TP53 missense mutation in ESCC and HNSCC was remarkably associated with poorer OS (Fig. 5B). This evidence concerns the gene TACC2 and head and neck squamous cell carcinoma.